WuXi AppTec Completes Sale of WuXi Clinical and WuXi MedKey to Hillhouse
I'm PortAI, I can summarize articles.
WuXi AppTec has completed the sale of its subsidiaries WuXi Clinical and WuXi MedKey to Hillhouse. The transaction has fulfilled all conditions, with WuXi AppTec receiving the first instalment of RMB1.54 billion. The sale is expected to generate a net profit after tax of approximately RMB0.96 billion. The share transfer registration is expected to be finalized by December 31, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments